Data / Form D filings / Inflammasome Therapeutics, Inc.
Inflammasome Therapeutics, Inc.: Form D filings
Inflammasome Therapeutics, Inc., a biotechnology company in Newton, MA, filed 4 Form D notices with the SEC between 2023 and 2026. The latest, on May 4, 2026, reports $13.2 million sold of a $13.2 million offering to 62 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 57 CHAPEL ST. STE. 100, Newton, MA, 02458
- Phone
- (617) 331-1071
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1989925
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 4, 2026 | New notice | $13,155,645 | $13,155,645 | 62 | Feb 27, 2026 | sec.gov | |
| Mar 17, 2025 | New notice | $10,000,000 | $2,450,172 | $7,549,828 | 27 | Dec 2, 2024 | sec.gov |
| Jan 26, 2024 | Amendment | $3,796,600 | $3,796,600 | 24 | Aug 4, 2023 | sec.gov | |
| Aug 14, 2023 | New notice | $3,796,600 | $2,796,600 | $1,000,000 | 24 | Aug 4, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jayakrishna Ambati | Executive Officer, Director | |
| Balamurali K. Ambati | Executive Officer, Director | |
| Chaniyilparampu N. Ramchand | Director | |
| Napoleone Ferrara | Director | |
| Babur B. Lateef | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of May 4, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Inflammasome Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.